Exfoliative toxins of Staphylococcus aureus

Toxins

Volumn 2, Issue 5, 2010, Pages 1148-1165

  Bukowski, Michal ^a   Wladyka, Benedykt ^a   Dubin, Grzegorz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Bullous impetigo; Epidermolytic toxin; Exfoliative toxin; Staphylococcal scalded skin syndrome; Staphylococcus aureus

Indexed keywords

DESMOGLEIN 1; DESMOGLEIN 3; EXFOLIATIN;

AMINO ACID SEQUENCE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BLISTER; DEHYDRATION; ENZYME SPECIFICITY; HUMAN; IMPETIGO BULLOSA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN EXFOLIATIVE DERMATITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; REVIEW; SECONDARY INFECTION; SKIN EXFOLIATION; SPECIES DIFFERENCE; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; BACTERIAL TOXINS; ENTEROTOXINS; EXFOLIATINS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SKIN; SPECIES SPECIFICITY; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; VIRULENCE FACTORS;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 79952060990     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins2051148     Document Type: Review

References (106)

1. Dinges, M.M.; Orwin, P.M.; Schlievert, P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 2000, 13, 16-34, table of contents.
2. Proft, T. In Microbial Toxins: Current Research and Future Trends; Caister Academic Press: Norfolk, UK, 2009; pp. 147-166.
3. Cribier, B.; Piemont, Y.; Grosshans, E. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J. Am. Acad. Dermatol. 1994, 30, 319-324.
4. Hardwick, N.; Parry, C.M.; Sharpe, G.R. Staphylococcal scalded skin syndrome in an adult. Influence of immune and renal factors. Br. J. Dermatol. 1995, 132, 468-471.
5. Ladhani, S.; Joannou, C.L.; Lochrie, D.P.; Evans, R.W.; Poston, S.M. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin. Microbiol. Rev. 1999, 12, 224-242.
6. Lyell, A. Toxic epidermal necrolysis. Nurs. Mirror Midwives J. 1973, 136, 42-45.
7. Payne, A.S.; Hanakawa, Y.; Amagai, M.; Stanley, J.R. Desmosomes and disease: pemphigus and bullous impetigo. Curr. Opin. Cell. Biol. 2004, 16, 536-543.
8. Johnson, W.M.; Tyler, S.D.; Ewan, E.P.; Ashton, F.E.; Pollard, D.R.; Rozee, K.R. Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J. Clin. Microbiol. 1991, 29, 426-430.
9. Raymond, J.; Bingen, E.; Brahimi, N.; Bergeret, M.; Lepercq, J.; Badoual, J.; Gendrel, D. Staphylococcal scalded skin syndrome in a neonate. Eur. J. Clin. Microbiol. Infect. Dis. 1997, 16, 453-454.
10. Sakurai, S.; Suzuki, H.; Machida, K. Rapid identification by polymerase chain reaction of staphylococcal exfoliative toxin serotype A and B genes. Microbiol. Immunol. 1995, 39, 379-386.
11. Melish, M.E.; Glasgow, L.A. Staphylococcal scalded skin syndrome: the expanded clinical syndrome. J. Pediatr. 1971, 78, 958-967.
12. Megevand, C.; Gervaix, A.; Heininger, U.; Berger, C.; Aebi, C.; Vaudaux, B.; Kind, C.; Gnehm, H.P.; Hitzler, M.; Renzi, G.; Schrenzel, J.; Francois, P. Molecular epidemiology of the nasal colonization by methicillin-susceptible Staphylococcus aureus in Swiss children. Clin. Microbiol. Infect. 2009, article online in advance of print.
13. Sila, J.; Sauer, P.; Kolar, M. Comparison of the prevalence of genes coding for enterotoxins, exfoliatins, panton-valentine leukocidin and tsst-1 between methicillin-resistant and methicillinsusceptible isolates of Staphylococcus aureus at the university hospital in olomouc. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech Repub. 2009, 153, 215-218.
14. Yamaguchi, T.; Yokota, Y.; Terajima, J.; Hayashi, T.; Aepfelbacher, M.; Ohara, M.; Komatsuzawa, H.; Watanabe, H.; Sugai, M. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J. Infect. Dis. 2002, 185, 1511-1516.
15. Noguchi, N.; Nakaminami, H.; Nishijima, S.; Kurokawa, I.; So, H.; Sasatsu, M. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome. J. Clin. Microbiol. 2006, 44, 2119-2125.
16. Gemmell, C.G. Staphylococcal scalded skin syndrome. J. Med. Microbiol. 1995, 43, 318-327.
17. Wiley, B.B.; Allman, S.; Rogolsky, M.; Norden, C.W.; Glasgow, L.A. Staphylococcal scalded skin syndrome: potentiation by immunosuppression in mice; toxin-mediated exfoliation in a healthy adult. Infect. Immun. 1974, 9, 636-640.
18. Opal, S.M.; Johnson-Winegar, A.D.; Cross, A.S. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliatin B-producing Staphylococcus aureus. J. Clin. Microbiol. 1988, 26, 1283-1286.
19. El Helali, N.; Carbonne, A.; Naas, T.; Kerneis, S.; Fresco, O.; Giovangrandi, Y.; Fortineau, N.; Nordmann, P.; Astagneau, P. Nosocomial outbreak of staphylococcal scalded skin syndrome in neonates: epidemiological investigation and control. J. Hosp. Infect. 2005, 61, 130-138.
20. Von Rittershain, G.R. Die exfoliative dermatitis jungener senglinge. Z. Kinderheilkd 1878, 2, 3-23.
21. Lyell, A. A review of toxic epidermal necrolysis in Britain. Br. J. Dermatol. 1967, 79, 662-671.
22. Melish, M.E.; Glasgow, L.A.; Turner, M.D. The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin. J. Infect. Dis. 1972, 125, 129-140.
23. Kapral, F.A.; Miller, M.M. Product of Staphylococcus aureus responsible for the scalded-skin syndrome. Infect. Immun. 1971, 4, 541-545.
24. Arbuthnott, J.P.; Kent, J.; Lyell, A.; Gemmell, C.G. Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus. Br. J. Dermatol. 1971, 85, 145-149.
25. Melish, M.E.; Glasgow, L.A. The staphylococcal scalded-skin syndrome. N. Engl. J. Med. 1970, 282, 1114-1119.
26. Kondo, I.; Sakurai, S.; Sarai, Y. Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties. Infect. Immun. 1973, 8, 156-164.
27. Arbuthnott, J.P.; Billcliffe, B.; Thompson, W.D. Isoelectric focusing studies of staphylococcal epidermolytic toxin. FEBS Lett. 1974, 46, 92-95.
28. Johnson, A.D.; Metzger, J.F.; Spero, L. Production, purification, and chemical characterization of Staphylococcus aureus exfoliative toxin. Infect. Immun. 1975, 12, 1206-1210.
29. Dimond, R.L.; Wuepper, K.D. Purification and characterization of a staphylococcal epidermolytic toxin. Infect. Immun. 1976, 13, 627-633.
30. Kondo, I.; Sakurai, S.; Sarai, Y. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease. Infect. Immun. 1974, 10, 851-861.
31. Wiley, B.B.; Rogolsky, M. Molecular and serological differentiation of staphylococcal exfoliative toxin synthesized under chromosomal and plasmid control. Infect. Immun. 1977, 18, 487-494.
32. de Azavedo, J.; Arbuthnott, J.P. Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus. J. Med. Microbiol. 1981, 14, 341-344.
33. Adesiyun, A.A.; Lenz, W.; Schaal, K.P. Exfoliative toxin production by Staphylococcus aureus strains isolated from animals and human beings in Nigeria. Microbiologica 1991, 14, 357-362.
34. Kondo, I.; Sakurai, S.; Sarai, Y.; Futaki, S. Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome. J. Clin. Microbiol. 1975, 1, 397-400.
35. Yamasaki, O.; Yamaguchi, T.; Sugai, M.; Chapuis-Cellier, C.; Arnaud, F.; Vandenesch, F.; Etienne, J.; Lina, G. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins. J. Clin. Microbiol. 2005, 43, 1890-1893.
36. O'Toole, P.W.; Foster, T.J. Molecular cloning and expression of the epidermolytic toxin A gene of Staphylococcus aureus. Microb. Pathog. 1986, 1, 583-594.
37. Jackson, M.P.; Iandolo, J.J. Sequence of the exfoliative toxin B gene of Staphylococcus aureus. J. Bacteriol. 1986, 167, 726-728.
38. O'Toole, P.W.; Foster, T.J. Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus. J. Bacteriol. 1987, 169, 3910-3915.
39. Lee, C.Y.; Schmidt, J.J.; Johnson-Winegar, A.D.; Spero, L.; Iandolo, J.J. Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus. J. Bacteriol. 1987, 169, 3904-3909.
40. Johnson, A.D.; Spero, L.; Cades, J.S.; de Cicco, B.T. Purification and characterization of different types of exfoliative toxin from Staphylococcus aureus. Infect. Immun. 1979, 24, 679-684.
41. Lyon, G.J.; Novick, R.P. Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides 2004, 25, 1389-1403.
42. Sheehan, B.J.; Foster, T.J.; Dorman, C.J.; Park, S.; Stewart, G.S. Osmotic and growth-phase dependent regulation of the eta gene of Staphylococcus aureus: a role for DNA supercoiling. Mol. Gen. Genet. 1992, 232, 49-57.
43. Jarraud, S.; Lyon, G.J.; Figueiredo, A.M.; Gerard, L.; Vandenesch, F.; Etienne, J.; Muir, T.W.; Novick, R.P. Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J. Bacteriol. 2000, 182, 6517-6522.
44. Jarraud, S.; Mougel, C.; Thioulouse, J.; Lina, G.; Meugnier, H.; Forey, F.; Nesme, X.; Etienne, J.; Vandenesch, F. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect. Immun. 2002, 70, 631-641.
45. Lillibridge, C.B.; Melish, M.E.; Glasgow, L.A. Site of action of exfoliative toxin in the staphylococcal scaled-skin syndrome. Pediatrics 1972, 50, 728-738.
46. Yamaguchi, T.; Hayashi, T.; Takami, H.; Ohnishi, M.; Murata, T.; Nakayama, K.; Asakawa, K.; Ohara, M.; Komatsuzawa, H.; Sugai, M. Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADP-ribosyltransferase, EDIN-C. Infect. Immun. 2001, 69, 7760-7771.
47. Sakurai, S.; Suzuki, H.; Kondo, I. DNA sequencing of the eta gene coding for staphylococcal exfoliative toxin serotype A. J. Gen. Microbiol. 1988, 134, 711-717.
48. Dancer, S.J.; Garratt, R.; Saldanha, J.; Jhoti, H.; Evans, R. The epidermolytic toxins are serine proteases. FEBS Lett. 1990, 268, 129-132.
49. Barbosa, J.A.; Saldanha, J.W.; Garratt, R.C. Novel features of serine protease active sites and specificity pockets: sequence analysis and modelling studies of glutamate-specific endopeptidases and epidermolytic toxins. Protein Eng. 1996, 9, 591-601.
50. Bailey, C.J.; Redpath, M.B. The esterolytic activity of epidermolytic toxins. Biochem. J. 1992, 284 (Pt 1), 177-180.
51. Prevost, G.; Rifai, S.; Chaix, M.L.; Piemont, Y. Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin A is essential for biological activity. Infect. Immun. 1991, 59, 3337-3339.
52. Redpath, M.B.; Foster, T.J.; Bailey, C.J. The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus. FEMS Microbiol. Lett. 1991, 65, 151-155.
53. Rago, J.V.; Vath, G.M.; Tripp, T.J.; Bohach, G.A.; Ohlendorf, D.H.; Schlievert, P.M. Staphylococcal exfoliative toxins cleave alpha- and beta-melanocyte-stimulating hormones. Infect. Immun. 2000, 68, 2366-2368.
54. Bailey, C.J.; Smith, T.P. The reactive serine residue of epidermolytic toxin A. Biochem. J. 1990, 269, 535-537.
55. Vath, G.M.; Earhart, C.A.; Rago, J.V.; Kim, M.H.; Bohach, G.A.; Schlievert, P.M.; Ohlendorf, D.H. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry 1997, 36, 1559-1566.
56. Cavarelli, J.; Prevost, G.; Bourguet, W.; Moulinier, L.; Chevrier, B.; Delagoutte, B.; Bilwes, A.; Mourey, L.; Rifai, S.; Piemont, Y.; Moras, D. The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution. Structure 1997, 5, 813-824.
57. Vath, G.M.; Earhart, C.A.; Monie, D.D.; Iandolo, J.J.; Schlievert, P.M.; Ohlendorf, D.H. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry 1999, 38, 10239-10246.
58. Papageorgiou, A.C.; Plano, L.R.; Collins, C.M.; Acharya, K.R. Structural similarities and differences in Staphylococcus aureus exfoliative toxins A and B as revealed by their crystal structures. Protein Sci. 2000, 9, 610-618.
59. Ninomiya, J.; Ito, Y.; Takiuchi, I. Purification of protease from a mixture of exfoliative toxin and newborn-mouse epidermis. Infect. Immun. 2000, 68, 5044-5049.
60. Vaishnani, J. Superantigen. Indian J. Dermatol. Venereol. Leprol. 2009, 75, 540-544.
61. Morlock, B.A.; Spero, L.; Johnson, A.D. Mitogenic activity of staphylococcal exfoliative toxin. Infect. Immun. 1980, 30, 381-384.
62. Choi, Y.W.; Kotzin, B.; Herron, L.; Callahan, J.; Marrack, P.; Kappler, J. Interaction of Staphylococcus aureus toxin superantigens with human T cells. Proc. Natl. Acad. Sci. USA 1989, 86, 8941-8945.
63. Schrezenmeier, H.; Fleischer, B. Mitogenic activity of staphylococcal protein A is due to contaminating staphylococcal enterotoxins. J. Immunol. Methods 1987, 105, 133-137.
64. Fleischer, B.; Bailey, C.J. Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen. Med. Microbiol. Immunol. 1992, 180, 273-278.
65. Rago, J.V.; Vath, G.M.; Bohach, G.A.; Ohlendorf, D.H.; Schlievert, P.M. Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA). J. Immunol. 2000, 164, 2207-2213.
66. Monday, S.R.; Vath, G.M.; Ferens, W.A.; Deobald, C.; Rago, J.V.; Gahr, P.J.; Monie, D.D.; Iandolo, J.J.; Chapes, S.K.; Davis, W.C.; Ohlendorf, D.H.; Schlievert, P.M.; Bohach, G.A. Unique superantigen activity of staphylococcal exfoliative toxins. J. Immunol. 1999, 162, 4550-4559.
67. Nishifuji, K.; Sugai, M.; Amagai, M. Staphylococcal exfoliative toxins: molecular scissors of bacteria that attack the cutaneous defense barrier in mammals. J. Dermatol. Sci. 2008, 49, 21-31.
68. Hanakawa, Y.; Schechter, N.M.; Lin, C.; Nishifuji, K.; Amagai, M.; Stanley, J.R. Enzymatic and molecular characteristics of the efficiency and specificity of exfoliative toxin cleavage of desmoglein 1. J. Biol. Chem. 2004, 279, 5268-5277.
69. Jordon, R.E.; Sams, W.M., Jr.; Diaz, G.; Beutner, E.H. Negative complement immunofluorescence in pemphigus. J. Invest. Dermatol. 1971, 57, 407-410.
70. Stanley, J.R.; Koulu, L.; Thivolet, C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J. Clin. Invest. 1984, 74, 313-320.
71. Eyre, R.W.; Stanley, J.R. Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients. J. Exp. Med. 1987, 165, 1719-1724.
72. Getsios, S.; Huen, A.C.; Green, K.J. Working out the strength and flexibility of desmosomes. Nat. Rev. Mol. Cell Biol. 2004, 5, 271-281.
73. Angst, B.D.; Marcozzi, C.; Magee, A.I. The cadherin superfamily: diversity in form and function. J. Cell Sci. 2001, 114, 629-641.
74. Amagai, M.; Matsuyoshi, N.; Wang, Z.H.; Andl, C.; Stanley, J.R. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat. Med. 2000, 6, 1275-1277.
75. Amagai, M.; Yamaguchi, T.; Hanakawa, Y.; Nishifuji, K.; Sugai, M.; Stanley, J.R. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. J. Invest. Dermatol. 2002, 118, 845-850.
76. Yamaguchi, T.; Nishifuji, K.; Sasaki, M.; Fudaba, Y.; Aepfelbacher, M.; Takata, T.; Ohara, M.; Komatsuzawa, H.; Amagai, M.; Sugai, M. Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect. Immun. 2002, 70, 5835-5845.
77. Hanakawa, Y.; Schechter, N.M.; Lin, C.; Garza, L.; Li, H.; Yamaguchi, T.; Fudaba, Y.; Nishifuji, K.; Sugai, M.; Amagai, M.; Stanley, J.R. Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J. Clin. Invest. 2002, 110, 53-60.
78. Schechter, I.; Berger, A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 1967, 27, 157-162.
79. Hanakawa, Y.; Selwood, T.; Woo, D.; Lin, C.; Schechter, N.M.; Stanley, J.R. Calcium-dependent conformation of desmoglein 1 is required for its cleavage by exfoliative toxin. J. Invest. Dermatol. 2003, 121, 383-389.
80. Arnemann, J.; Sullivan, K.H.; Magee, A.I.; King, I.A.; Buxton, R.S. Stratification-related expression of isoforms of the desmosomal cadherins in human epidermis. J. Cell Sci. 1993, 104 (Pt 3), 741-750.
81. Plano, L.R.; Adkins, B.; Woischnik, M.; Ewing, R.; Collins, C.M. Toxin levels in serum correlate with the development of staphylococcal scalded skin syndrome in a murine model. Infect. Immun. 2001, 69, 5193-5197.
82. O'Keefe, R.; Dagg, J.H.; MacKie, R.M. The staphylococcal scalded skin syndrome in two elderly immunocompromised patients. Br. Med. J. (Clin. Res. Ed.) 1987, 295, 179-180.
83. Richard, M.; Mathieu-Serra, A. Staphylococcal scalded skin syndrome in a homosexual adult. J. Am. Acad. Dermatol. 1986, 15, 385-389.
84. Petzelbauer, P.; Konrad, K.; Wolff, K. [Staphylococcal scalded skin syndrome in 2 adults with acute kidney failure]. Hautarzt 1989, 40, 90-93.
85. Melish, M.E.; Chen, F.S.; Sprouse, S.; Stuckey, M.; Murata, M.S. Epidermolyic toxin in staphylococcal infection: toxin levels and host response. Zentralbl. Bakteriol. Suppl. 1981, 10, 287-298.
86. Bishop, G.A.; Waugh, J.A.; Hall, B.M. Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis. Transplantation 1988, 46, 303-310.
87. Wahl, P.; Schoop, R.; Bilic, G.; Neuweiler, J.; Le Hir, M.; Yoshinaga, S.K.; Wuthrich, R.P. Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J. Am. Soc. Nephrol. 2002, 13, 1517-1526.
88. Prodjosudjadi, W.; Gerritsma, J.S.; Klar-Mohamad, N.; Gerritsen, A.F.; Bruijn, J.A.; Daha, M.R.; van Es, L.A. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int. 1995, 48, 1477-1486.
89. Becker, K.; Friedrich, A.W.; Lubritz, G.; Weilert, M.; Peters, G.; Von Eiff, C. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J. Clin. Microbiol. 2003, 41, 1434-1439.
90. O'Reilly, M.; Dougan, G.; Foster, T.J.; Arbuthnott, J.P. Plasmids in epidermolytic strains of Staphylococcus aureus. J. Gen. Microbiol. 1981, 124, 99-107.
91. Elias, P.M.; Fritsch, P.; Mittermayer, H. Staphylococcal toxic epidermal necrolysis: species and tissue susceptibility and resistance. J. Invest. Dermatol. 1976, 66, 80-89.
92. Machida, K.; Sakurai, S.; Kondo, I.; Ikawa, S. Relationship between susceptibility and immune response to staphylococcal exfoliative toxin A in mammalian species. Microbiol. Immunol. 1988, 32, 1079-1084.
93. Sato, H.; Matsumori, Y.; Tanabe, T.; Saito, H.; Shimizu, A.; Kawano, J. A new type of staphylococcal exfoliative toxin from a Staphylococcus aureus strain isolated from a horse with phlegmon. Infect. Immun. 1994, 62, 3780-3785.
94. Yamasaki, O.; Tristan, A.; Yamaguchi, T.; Sugai, M.; Lina, G.; Bes, M.; Vandenesch, F.; Etienne, J. Distribution of the exfoliative toxin D gene in clinical Staphylococcus aureus isolates in France. Clin. Microbiol. Infect. 2006, 12, 585-588.
95. Sato, H.; Tanabe, T.; Kuramoto, M.; Tanaka, K.; Hashimoto, T.; Saito, H. Isolation of exfoliative toxin from Staphylococcus hyicus subsp. hyicus and its exfoliative activity in the piglet. Vet. Microbiol. 1991, 27, 263-275.
96. Sato, H.; Watanabe, T.; Murata, Y.; Ohtake, A.; Nakamura, M.; Aizawa, C.; Saito, H.; Maehara, N. New exfoliative toxin produced by a plasmid-carrying strain of Staphylococcus hyicus. Infect. Immun. 1999, 67, 4014-4018.
97. Andresen, L.O. Differentiation and distribution of three types of exfoliative toxin produced by Staphylococcus hyicus from pigs with exudative epidermitis. FEMS Immunol. Med. Microbiol. 1998, 20, 301-310.
98. Ahrens, P.; Andresen, L.O. Cloning and sequence analysis of genes encoding Staphylococcus hyicus exfoliative toxin types A, B, C, and D. J. Bacteriol. 2004, 186, 1833-1837.
99. Sato, H.; Watanabe, T.; Higuchi, K.; Teruya, K.; Ohtake, A.; Murata, Y.; Saito, H.; Aizawa, C.; Danbara, H.; Maehara, N. Chromosomal and extrachromosomal synthesis of exfoliative toxin from Staphylococcus hyicus. J. Bacteriol. 2000, 182, 4096-4100.
100. Sato, H.; Kuramoto, M.; Tanabe, T.; Saito, H. Susceptibility of various animals and cultured cells to exfoliative toxin produced by Staphylococcus hyicus subsp. hyicus. Vet. Microbiol. 1991, 28, 157-169.
101. Terauchi, R.; Sato, H.; Hasegawa, T.; Yamaguchi, T.; Aizawa, C.; Maehara, N. Isolation of exfoliative toxin from Staphylococcus intermedius and its local toxicity in dogs. Vet. Microbiol. 2003, 94, 19-29.
102. Sato, H.; Hirose, K.; Terauchi, R.; Abe, S.; Moromizato, I.; Kurokawa, S.; Maehara, N. Purification and characterization of a novel Staphylococcus chromogenes exfoliative toxin. J. Vet. Med. B. Infect. Di.s Vet. Public Health 2004, 51, 116-122.
103. Andresen, L.O.; Ahrens, P.; Daugaard, L.; Bille-Hansen, V. Exudative epidermitis in pigs caused by toxigenic Staphylococcus chromogenes. Vet. Microbiol. 2005, 105, 291-300.
104. Futagawa-Saito, K.; Makino, S.; Sunaga, F.; Kato, Y.; Sakurai-Komada, N.; Ba-Thein, W.; Fukuyasu, T. Identification of first exfoliative toxin in Staphylococcus pseudintermedius. FEMS Microbiol. Lett. 2009, 301, 176-180.
105. Yamaguchi, T.; Hayashi, T.; Takami, H.; Nakasone, K.; Ohnishi, M.; Nakayama, K.; Yamada, S.; Komatsuzawa, H.; Sugai, M. Phage conversion of exfoliative toxin A production in Staphylococcus aureus. Mol. Microbiol. 2000, 38, 694-705.
106. Dryla, A.; Prustomersky, S.; Gelbmann, D.; Hanner, M.; Bettinger, E.; Kocsis, B.; Kustos, T.; Henics, T.; Meinke, A.; Nagy, E. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin. Diagn. Lab. Immunol. 2005, 12, 387-398.